CMA involves extracting DNA from a neonatal sample, usually blood. The DNA is then hybridized to a microarray chip that contains thousands of DNA probes. These probes can identify gains or losses of DNA segments throughout the genome. The resulting data is analyzed using specialized software to detect any significant deviations from the normal DNA sequence.
